Singh Christopher R, Moulton Rachel A, Armitige Lisa Y, Bidani Akhil, Snuggs Mark, Dhandayuthapani Subramanian, Hunter Robert L, Jagannath Chinnaswamy
Department of Pathology and Laboratory Medicine, University of Texas Health Science Center, Houston 77030, USA.
J Immunol. 2006 Sep 1;177(5):3250-9. doi: 10.4049/jimmunol.177.5.3250.
Mycobacterium tuberculosis (strain H37Rv) and bacillus Calmette-Guérin (BCG) vaccine inhibit phagosome maturation in macrophages and their effect on processing, and presentation of a secreted Ag85 complex B protein, Ag85B, by mouse macrophages was analyzed. Macrophages were infected with GFP-expressing mycobacterial strains and analyzed for in situ localization of vacuolar proton ATPase (v-ATPase) and cathepsin D (Cat D) using Western blot analysis and immunofluorescence. H37Rv and BCG phagosomes excluded the v-ATPase and maintained neutral pH while the attenuated H37Ra strain acquired v-ATPase and acidified. Mycobacterial phagosomes acquired Cat D, although strains BCG and H37Rv phagosomes contained the inactive 46-kDa form, whereas H37Ra phagosomes had the active 30-kDa form. Infected macrophages were overlaid with a T cell hybridoma specific for an Ag85B epitope complexed with MHC class II. Coincident with active Cat D, H37Ra-infected macrophages presented the epitope to T cells inducing IL-2, whereas H37Rv- and BCG-infected macrophages were less efficient in IL-2 induction. Bafilomycin inhibited the induction of macrophage-induced IL-2 from T cells indicating that v-ATPase was essential for macrophage processing of Ag85B. Furthermore, the small interfering RNA interference of Cat D synthesis resulted in a marked decrease in the levels of macrophage-induced IL-2. Thus, a v-ATPase-dependent phagosomal activation of Cat D was required for the generation of an Ag85B epitope by macrophages. Reduced processing of Ag85B by H37Rv- and BCG-infected macrophages suggests that phagosome maturation arrest interferes with the efficient processing of Ags in macrophages. Because Ag85B is immunodominant, this state may lead to a decreased ability of the wild-type as well as the BCG vaccine to induce protective immunity.
结核分枝杆菌(菌株H37Rv)和卡介苗(BCG)疫苗可抑制巨噬细胞中吞噬体的成熟,并分析了它们对小鼠巨噬细胞加工和呈递分泌型Ag85复合蛋白B(Ag85B)的影响。用表达绿色荧光蛋白的分枝杆菌菌株感染巨噬细胞,并使用蛋白质免疫印迹分析和免疫荧光法分析液泡质子ATP酶(v-ATPase)和组织蛋白酶D(Cat D)的原位定位。H37Rv和BCG吞噬体排除了v-ATPase并维持中性pH值,而减毒的H37Ra菌株获得了v-ATPase并酸化。分枝杆菌吞噬体获得了Cat D,尽管BCG和H37Rv菌株的吞噬体含有无活性的46 kDa形式,而H37Ra吞噬体具有活性的30 kDa形式。用对与MHC II类复合的Ag85B表位特异的T细胞杂交瘤覆盖感染的巨噬细胞。与活性Cat D一致,H37Ra感染的巨噬细胞将表位呈递给T细胞以诱导IL-2,而H37Rv和BCG感染的巨噬细胞在诱导IL-2方面效率较低。巴弗洛霉素抑制了巨噬细胞诱导的T细胞IL-2的诱导,表明v-ATPase对于巨噬细胞加工Ag85B至关重要。此外,Cat D合成的小干扰RNA干扰导致巨噬细胞诱导的IL-2水平显著降低。因此,巨噬细胞产生Ag85B表位需要v-ATPase依赖性的Cat D吞噬体激活。H37Rv和BCG感染的巨噬细胞对Ag85B的加工减少表明吞噬体成熟停滞会干扰巨噬细胞中抗原的有效加工。由于Ag85B具有免疫优势,这种状态可能导致野生型以及BCG疫苗诱导保护性免疫的能力下降。